- Debate on Treatment for IgA Nephropathy
-
Jicheng Lv
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Understanding the Pathological Role of APRIL in IgA Nephropathy
-
Yusuke Suzuki
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Current Treatment and the Updates in IgA Nephropathy
-
Hong Zhang
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Policies to Reduce Medical Costs in ESKD Care. Experience With PD First Policy
-
Philip Kam-Tao Li
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Past, Present, and Future of Policies for Chronic Disease Control
-
Eun-kyung Jeong
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- International Efforts Against CKD Pandemic
-
Masaomi Nangaku
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Progress of KHP2033 in Korea
-
Sun-Hee Park
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- How will Treatment for IgA Nephropathy Evolve over the Next 5 Years?
-
Jonathan Barratt
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Nafamostat as an Anticoagulant on CRRT
-
Jung Nam Ahn
2024 ; 2024(1):
-
초록보기
PDF 원문보기
- Uremic Toxins as a Potential Therapeutic Target for Kidney, Heart, and Beyond
-
Jwa-kyung Kim
2024 ; 2024(1):
-
초록보기
PDF 원문보기